Use your antibodies-online credentials, if available.
No Products on your Comparison List.
Your basket is empty.
Find out more
Chemotactic factor that attracts monocytes and eosinophils, but not neutrophils. Additionally we are shipping CCL7 Kits (74) and CCL7 Proteins (73) and many more products for this protein.
Showing 10 out of 226 products:
Enzyme-linked immunosorbent assay was used to detect the levels of chemokine (C-X-C motif) ligand 12, chemokine (C-X-C motif) ligand 7, hepatocyte growth factor, and fibroblast growth factor 1 in the supernatants of the laryngeal squamous cell carcinoma and control cells.
Periprostatic adipocytes drive prostate cancer progression in obesity via CCL7 secretion which stimulates CCR3 (show CCR3 Antibodies) expressing tumor cells.
These results suggest that let-7d may suppress renal cell carcinoma (show MOK Antibodies) growth, metastasis, and tumor macrophage infiltration at least partially through targeting COL3A1 (show COL3A1 Antibodies) and CCL7.
Based on nasopharyngeal CCL7 gene expression in readily available Nasopharyngeal aspirate samples , we can discriminate between severity of disease in Respiratory syncytial virus infected infants.
Overexpression of ISL1 in human mesnchymal stem cells promotes angiogenesis in vitro and in vivo through increasing secretion of MCP3 and other paracrine factors.
Data indicate that different glycosaminoglycan-binding properties of monocyte chemoattractant protein-3/CCL7 and monocyte chemoattractant protein (MCP)-1/CCL2 (show CCL2 Antibodies) suggest non-redundant functions and regulation.
Our data demonstrate that the monocyte-specific chemokine (show CCL1 Antibodies) CCL7 and its receptor CCR2 (show CCR2 Antibodies) are expressed in tumour cells of RCC (show XRCC1 Antibodies)
Systemic IFN-gamma triggered the secretion of C-C motif ligand chemokines CCL2 and CCL7 leading to the egress of early, myeloid-committed progenitors from the bone marrow mediated by their common receptor CCR2.
Anticancer effect of desmethyl-lasiodiplodin is mediated, in part, by upregulation of apoptotic genes and downregulation of MCP-3.
Immunohistochemistry and real-time PCR analysis showed that CCL7 was expressed in normal colonic epithelium and the expression was higher in liver metastases compared to primary CRC (show CALR Antibodies).
The suppression of nasal inflammation due of IL-17A (show IL17A Antibodies) deficiency in allergic rhinitis is partly responsible for the regulation of CCL7 secretion and eosinophil infiltration, which may be regulated via the CCL7/CCR3 (show CCR3 Antibodies) pathway.
Our results demonstrate that CCL7 is required for maximal ovalbumin (show OVA Antibodies)-induced ocular anaphylaxis, mast cell recruitment in vivo, and maximal FcepsilonRI (show FCER1A Antibodies)-mediated mast cell activation in vitro
Data show that monocyte accumulation in the brain is dependent on chemokines CCL2 (show CCL2 Antibodies) and CCL7.
TFPI (show TFPI Antibodies) has an anti-proliferative role in TNF-alpha (show TNF Antibodies) stimulated-VSMCs at least partly by interfering with the MCP-3/CCR2 (show CCR2 Antibodies) pathway and then via suppression of the ERK1/2 (show MAPK1/3 Antibodies) and PI3K/AKT (show AKT1 Antibodies) signaling pathways
Our data highlight a pivotal role of CCL7 and IRF-7 (show IRF7 Antibodies) in rhinovirus-induced inflammation
tumours are characterized by expression of inflammatory chemokines (CCL2 (show CCL2 Antibodies), CCL5 (show CCL5 Antibodies), CCL7, CCL8 (show CCL8 Antibodies), CCL12 (show Ccl12 Antibodies), CXCL9 (show CXCL9 Antibodies), CXCL10 (show CXCL10 Antibodies) and CX3CL1 (show CX3CL1 Antibodies)), reflected by an enrichment of activated Foxp3 (show FOXP3 Antibodies)(-) and Foxp3 (show FOXP3 Antibodies)(+) T cells
The intranasal administration of recombinant CCL2 (show CCL2 Antibodies) (rCCL2) and rCCL7.
CCL7 has a dual role in the development of renal tubular interstitial fibrosis, deleterious in early stages but beneficial during later stages
These findings suggest that aortic MCP-3 overexpression may contribute to the development of atherosclerosis and hepatic steatosis under atherogenic conditions.
Chemotactic factor that attracts monocytes and eosinophils, but not neutrophils. Augments monocyte anti-tumor activity. Also induces the release of gelatinase B. This protein can bind heparin. Binds to CCR1, CCR2 and CCR3.
chemokine (C-C motif) ligand 7
, C-C motif chemokine 7
, monocyte chemoattractant protein 3
, monocyte chemotactic protein 3
, small inducible cytokine A7 (monocyte chemotactic protein 3)
, small-inducible cytokine A7
, RANTES/sis homolog
, intercrine/chemokine MARC
, small inducible cytokine A7
, chemotactic protein-3